Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes

被引：52
|
作者：
Hedman, CA
Lindstrom, T
Arnqvist, HJ
机构：
[1] Linkoping Univ, Dept Med & Care, Div Internal Med, Linkoping, Sweden
[2] Linkoping Univ, Fac Hlth Sci, Dept Biomed & Surg, Div Cellbiol, Linkoping, Sweden
来源：
DIABETES CARE | 2001年 / 24卷 / 06期
关键词：
D O I：
10.2337/diacare.24.6.1120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1120 / 1121
页数：2
相关论文
共 50 条
  • [1] Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneuos injection in type 1 diabetes
    Hedman, CA
    Lindstrom, T
    Arnqvist, HJ
    DIABETES, 2001, 50 : A116 - A116
  • [2] A direst comparison of insulin aspart and insulin lispro in patients with type 1 diabetes
    Plank, J
    Wutte, A
    Brunner, G
    Siebenhofer, A
    Semlitsch, B
    Sommer, R
    Hirschberger, S
    Pieber, TR
    DIABETES CARE, 2002, 25 (11) : 2053 - 2057
  • [3] Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion - A randomized study in type 1 diabetes
    Bode, B
    Raskin, P
    Weinstein, R
    Davidson, J
    Bell, D
    Henry, R
    McGill, J
    Huang, WC
    Nadeau, D
    Reinhardt, RR
    DIABETES CARE, 2002, 25 (03) : 439 - 444
  • [4] A direct comparison of insulin analogs aspart and lispro in type 1 diabetic patients
    Plank, J
    Wutte, A
    Goerzer, E
    Siebenhofer, A
    Semlitsch, B
    Sommer, R
    Hirschberger, S
    Pieber, TR
    DIABETES, 2002, 51 : A52 - A52
  • [5] Insulin aspart versus insulin lispro via continuous subcutaneous insulin infusion (CSII) in children and adolescents with type 1 diabetes
    Weinzimer, Stuart
    Laffel, Lori
    Ternand, Christine
    Howard, Campbell
    Chang, C. T.
    Becker, Dorothy
    DIABETES, 2007, 56 : A478 - A478
  • [6] Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes
    Garg, S. K.
    Buse, J. B.
    Skyler, J. S.
    Vaughn, D. E.
    Muchmore, D. B.
    DIABETES OBESITY & METABOLISM, 2014, 16 (11): : 1065 - 1069
  • [7] A Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion of Insulin Aspart Versus Insulin Lispro in Children and Adolescents With Type 1 Diabetes
    Weinzimer, Stuart A.
    Ternand, Christine
    Howard, Campbell
    Chang, Cheng-Tao
    Becker, Dorothy J.
    Laffel, Lori M. B.
    DIABETES CARE, 2008, 31 (02) : 210 - 215
  • [8] INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART
    Thrasher, James
    Bhargava, Anuj
    Rees, Tina M.
    Wang, Tao
    Guzman, Cristina B.
    Glass, Leonard C.
    ENDOCRINE PRACTICE, 2015, 21 (03) : 247 - 257
  • [9] Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial
    van Bon, Arianne C.
    Bode, Bruce W.
    Sert-Langeron, Caroline
    DeVries, J. Hans
    Charpentier, Guillaume
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (06) : 607 - 614
  • [10] BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
    Heise, Tim
    Meiffren, Gregory
    Alluis, Bertrand
    Seroussi, Cyril
    Ranson, Aymeric
    Arrubla, Jorge
    Correia, Jose
    Gaudier, Martin
    Soula, Olivier
    Soula, Remi
    DeVries, J. Hans
    Klein, Oliver
    Bode, Bruce
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1066 - 1070
12345